1. Determinants of variation in radical local treatment for men with high-risk localised or locally advanced prostate cancer in England
- Author
-
Melanie Morris, Jemma M. Boyle, Matthew G. Parry, Heather Payne, Arunan Sujenthiran, Noel W. Clarke, Julie Nossiter, Jan van der Meulen, Ajay Aggarwal, Paul Cathcart, and Brendan Berry
- Subjects
Cancer Research ,medicine.medical_specialty ,business.industry ,Urology ,Locally advanced ,Ethnic group ,medicine.disease ,Logistic regression ,Comorbidity ,Prostate cancer ,Variation (linguistics) ,Oncology ,Older patients ,Internal medicine ,Medicine ,business ,Socioeconomic status - Abstract
Many factors are implicated in the potential ‘under-treatment’ of prostate cancer but little is known about the between-hospital variation. The National Prostate Cancer Audit (NPCA) database was used to identify high-risk localised or locally advanced prostate cancer patients in England, between January 2014 and December 2017, and the treatments received. Hospital-level variation in radical local treatment was explored visually using funnel plots. The intra-class correlation coefficient (ICC) quantified the between-hospital variation in a random-intercept multivariable logistic regression model. 53,888 men, from 128 hospitals, were included and 35,034 (65.0%) received radical local treatment. The likelihood of receiving radical local treatment was increased in men who were younger (the strongest predictor), more affluent, those with fewer comorbidities, and in those with a non-Black ethnic background. There was more between-hospital variation (P
- Published
- 2021
- Full Text
- View/download PDF